Literature DB >> 30084975

Association of Either Left Ventricular Hypertrophy or Diastolic Dysfunction With 24-Hour Central and Peripheral Blood Pressure.

Pedro Blanch1, Pedro Armario1, Anna Oliveras2, Patricia Fernández-Llama3, Susana Vázquez2, Julia Pareja4, Empar Álvarez5, Francesca Calero3, Cristina Sierra6, Alejandro de la Sierra4.   

Abstract

BACKGROUND: Central blood pressure (BP) is considered as a better estimator of hypertension-associated risks than peripheral BP. We aimed to evaluate the association of 24-hour central BP, in comparison with 24-hour peripheral BP, with the presence of left ventricular hypertrophy (LVH), or diastolic dysfunction (DD).
METHODS: The cross-sectional study consisted of 208 hypertensive patients, aged 57 ± 12 years, of which 34% were women. Office and 24-hour central and peripheral BP were measured by the oscillometric Mobil-O-Graph device. We performed echocardiography-Doppler measurements to calculate LVH and DD, defined as left atrium volume ≥34 ml/m2 or septal e' velocity <8 cm/s or lateral e' velocity <10 cm/s.
RESULTS: Seventy-seven patients (37%) had LVH, and 110 patients (58%) had DD. Systolic and pulse BP estimates (office, 24-hour, daytime, and nighttime) were associated with the presence of LVH or DD, after adjustment for age, gender, and antihypertensive treatment, with higher odds ratios for ambulatory-derived values. The comparison between central and peripheral BP estimates did not reveal a statistically significant superiority of the former neither in multiple regression models with simultaneous adjustments nor in the comparison of areas under receiver-operating curves. Correlation coefficients of BP estimates with left ventricular mass, although numerically higher for central BP, did not significantly differ between central and peripheral BP.
CONCLUSIONS: We have not found a significant better association of 24-hour central over peripheral BP, with hypertensive cardiac alterations, although due to the sample size, these results require further confirmation in order to assess the possible role of routine 24-hour central BP measurement.

Entities:  

Mesh:

Year:  2018        PMID: 30084975     DOI: 10.1093/ajh/hpy123

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  2 in total

Review 1.  Ambulatory monitoring of central arterial pressure, wave reflections, and arterial stiffness in patients at cardiovascular risk.

Authors:  Stefano Omboni; Ayana Arystan; Bela Benczur
Journal:  J Hum Hypertens       Date:  2021-09-13       Impact factor: 3.012

2.  Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy.

Authors:  Liang Mao; Yun-Da Li; Ruo-Lan Chen; Gang Li; Xiao-Xia Zhou; Fei Song; Chan Wu; Yu Hu; Yi-Xiang Hong; Xitong Dang; Gui-Rong Li; Yan Wang
Journal:  J Nanobiotechnology       Date:  2022-10-04       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.